日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and Characterization of the First Selective Class IIb Histone Deacetylase Degraders.

首个选择性 IIb 类组蛋白去乙酰化酶降解剂的开发和表征

Zhai Shiyang, Honin Irina, Schäker-Hübner Linda, Hanl Maria, Jacobi Lukas, Dressler Finn, Pieńkowska Dominika Ewa, König Philipp, Gerhartz Jan, Voget Rabea, Bendas Gerd, Gütschow Michael, Meissner Felix, Burckhardt Bjoern B, Nowak Radosław P, Steinebach Christian, Hansen Finn K

Salamandamide Lipodipeptides Are Biosynthetic Intermediate Shunt Products of the Nonamodular Nonribosomal Peptide Assembly Lines of the Viscosin Family

沙门氏酰胺脂二肽是粘蛋白家族非模块非核糖体肽组装线的生物合成中间体旁路产物

Bhattarai, Keshab; Majer, Thomas; Haussmann, Manuela; Schollmeyer, Dieter; Kramer, Markus; Oni, Feyisara Eyiwumi; Höfte, Monica; Voget, Rabea; Gütschow, Michael; Ruetalo, Natalia; Schindler, Michael; Straetener, Jan; Wannenwetsch, Tatjana; Brötz-Oesterhelt, Heike; Karongo, Ryan; Masberg, Benedikt; Lämmerhofer, Michael; Hennessy, Rosanna Catherine; Muletz-Wolz, Carly R; Gross, Harald

Sequential Optimization Approach Toward an Azapeptide-Based SARS-CoV-2 Main Protease Inhibitor

基于氮杂肽的SARS-CoV-2主蛋白酶抑制剂的序列优化方法

Voget, Rabea; Steiger, Victoria; Breidenbach, Julian; Sylvester, Katharina; Müller-Ruttloff, Christin; Yang, Chun-Chiao; Ziebuhr, John; Sträter, Norbert; Müller, Christa E; Gütschow, Michael

Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics

开发 SARS-CoV-2 主蛋白酶活性位点滴定剂作为评估酶动力学不可或缺的工具

Rabea Voget, Julian Breidenbach, Tobias Claff, Alexandra Hingst, Katharina Sylvester, Christian Steinebach, Lan Phuong Vu, Renato H Weiße, Ulrike Bartz, Norbert Sträter, Christa E Müller, Michael Gütschow

Macrocyclic Azapeptide Nitriles: Structure-Based Discovery of Potent SARS-CoV-2 Main Protease Inhibitors as Antiviral Drugs

大环氮杂肽腈:基于结构发现有效的 SARS-CoV-2 主要蛋白酶抑制剂作为抗病毒药物

Julian Breidenbach, Rabea Voget, Yaoyao Si, Alexandra Hingst, Tobias Claff, Katharina Sylvester, Valentina Wolf, Vesa Krasniqi, Abibe Useini, Norbert Sträter, Yukino Ogura, Atsushi Kawaguchi, Christa E Müller, Michael Gütschow

Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity

针对组织蛋白酶的 SARS-CoV-2 抑制剂:设计、合成和生物活性

Philipp Flury, Julian Breidenbach, Nadine Krüger, Rabea Voget, Laura Schäkel, Yaoyao Si, Vesa Krasniqi, Sara Calistri, Matthias Olfert, Katharina Sylvester, Cheila Rocha, Raphael Ditzinger, Alexander Rasch, Stefan Pöhlmann, Thales Kronenberger, Antti Poso, Katharina Rox, Stefan A Laufer, Christa E M

Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity"

对“靶向组织蛋白酶的SARS-CoV-2抑制剂:设计、合成和生物活性”的更正

Flury, Philipp; Breidenbach, Julian; Krüger, Nadine; Voget, Rabea; Schäkel, Laura; Si, Yaoyao; Krasniqi, Vesa; Calistri, Sara; Olfert, Matthias; Sylvester, Katharina; Rocha, Cheila; Ditzinger, Raphael; Rasch, Alexander; Pöhlmann, Stefan; Kronenberger, Thales; Poso, Antti; Rox, Katharina; Laufer, Stefan A; Müller, Christa E; Gütschow, Michael; Pillaiyar, Thanigaimalai

Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART

替诺福韦-拉米夫定-多替拉韦治疗对接受二线抗逆转录病毒疗法(ART)失败的成人患者的病毒学疗效

Zhao, Ying; Voget, Jacqueline; Singini, Isaac; Omar, Zaayid; Mudaly, Vanessa; Boulle, Andrew; Maartens, Gary; Meintjes, Graeme

Revisiting the antiangiogenic mechanisms of fluorinated thalidomide derivatives

重新审视氟化沙利度胺衍生物的抗血管生成机制

Sievers, Johannes; Voget, Rabea; Lu, Feiteng; Garchitorena, Kathleen M; Ng, Yuen Lam Dora; Chau, Cindy H; Steinebach, Christian; Figg, William D; Krönke, Jan; Gütschow, Michael

HIV Drug Resistance in Newly Diagnosed Young Children in the Western Cape, South Africa

南非西开普省新确诊幼儿艾滋病毒耐药性

Anderson, Kim; van Zyl, Gert; Hsiao, Nei-Yuan; Claassen, Mathilda; Mudaly, Vanessa; Voget, Jacqueline; Heekes, Alexa; Kalk, Emma; Phelanyane, Florence; Boulle, Andrew; Sridhar, Gayathri; Ragone, Leigh; Vannappagari, Vani; Davies, Mary-Ann